A Study of SGN-B6A in Chinese Participants With Advanced Solid Tumors

Clinical trial NCT06549816 · COMPLETED

Trial details

NCT number: NCT06549816
Sponsor: Seagen, a wholly owned subsidiary of Pfizer
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Carcinoma, Non-Small Cell Lung Squamous Cell Carcinoma of Head and Neck Esophageal Squamous Cell Carcinoma Gastric Adenocarcinoma Esophageal Adenocarcinoma Gastroesophageal Junction Adenocarcinoma

Start date: 2024-08-21
Primary completion: 2025-11-18
Enrollment: 6

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.